Triumpharma Inc. is a pioneer in developing systems and solutions for advanced drug delivery. We strive to bridge the gap between life science and modern healthcare.

Triumpharma Inc. develops technologies that enhance the performance of many of today's commonly available pharmaceutical products and new chemical entities that give raise to challenging bioavailability problems.

Triumpharma has strong technical capabilities to take products from feasibility to pilot scale. Triumpharma conducts formulation optimization studies, pre-clinical trials on animals, human clinical studies including bioavailability/ bioequivalence trial complying with the international guidelines. The company's core advantages are its extremely low-cost base, experienced staff with multi national experience, holding PhDs from western universities, high-quality research, a large pool of patient’s and volunteers, and fast formulation development meeting the necessary regulatory requirements.

The Project Management unit (PMU) act as the liaison between the Sponsor, team members including local and regional CRAs, and sites while managing projects to ensure a service of the highest quality. Responsibilities encompass the overall management of a project including timeline adherence, internal and external communications, and project deliverables.

The project management offer

  • Leadership for High Performance Support Teams
  • Prepare Clinical Project Deliverables; Protocols, CRFs, Clinical Study Tools
  • Identify Qualified PIs and Prepare Investigational Site Lists
  • Participate in Reviewing and Approving Investigational Sites
  • Planning of Investigator Meetings
  • Development and Achievement of Project Milestones
  • Support of Accurate Enrollment Forecasting And Enrollment
  • Study Budget Forecasting and Contract Negotiation

This publication has been produced with the assistance of the European Union in cooperation with Jordan Enterprise Development Corporation. *

* The contents of this publication are the sole responsibility of Triumpharma and can in no way betaken to reflect the views of the European Union & Jordan Enterprise Development Corporation